Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 54.32%-4.28M | ---- | 37.48%-9.36M | ---- | 32.25%-14.97M | ---- | 19.21%-22.09M | ---- | -8.67%-27.34M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -20.98%-444K | ---- | -2.80%-367K | ---- | -0.28%-357K | ---- | 0.28%-356K | ---- | -181.10%-357K |
| Interest expense - adjustment | ---- | 35.42%780K | ---- | -84.42%576K | ---- | -34.25%3.7M | ---- | 19.82%5.62M | ---- | 22.18%4.69M |
| Attributable subsidiary (profit) loss | ---- | 124.71%735K | ---- | 17.18%-2.98M | ---- | -8.88%-3.59M | ---- | 1.76%-3.3M | ---- | -525.33%-3.36M |
| Impairment and provisions: | ---- | 7.67%1.32M | ---- | -60.52%1.23M | ---- | -58.08%3.11M | ---- | -21.16%7.41M | ---- | 729.21%9.4M |
| -Impairment of property, plant and equipment (reversal) | ---- | --155K | ---- | ---- | ---- | -64.79%1.89M | ---- | 4,001.53%5.37M | ---- | -75.70%131K |
| -Impairmen of inventory (reversal) | ---- | 695.45%525K | ---- | -91.25%66K | ---- | 247.27%754K | ---- | -247.98%-512K | ---- | --346K |
| -Impairment of trade receivables (reversal) | ---- | 50.00%57K | ---- | 133.93%38K | ---- | -918.18%-112K | ---- | ---11K | ---- | ---- |
| -Other impairments and provisions | ---- | -48.04%583K | ---- | 96.50%1.12M | ---- | -77.67%571K | ---- | -71.33%2.56M | ---- | 1,396.31%8.92M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | -89.14%49K | ---- | -82.26%451K | ---- | -63.21%2.54M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | -89.14%49K | ---- | -82.26%451K | ---- | --2.54M |
| Depreciation and amortization: | ---- | -24.84%2.07M | ---- | -43.65%2.76M | ---- | -44.81%4.89M | ---- | 108.39%8.87M | ---- | -23.72%4.26M |
| -Amortization of intangible assets | ---- | 0.00%176K | ---- | 70.87%176K | ---- | --103K | ---- | ---- | ---- | ---- |
| Exchange Loss (gain) | ---- | -69.69%714K | ---- | -16.31%2.36M | ---- | --2.82M | ---- | ---- | ---- | ---- |
| Special items | ---- | ---567K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 105.81%336K | ---- | -32.75%-5.78M | ---- | -28.18%-4.36M | ---- | 66.59%-3.4M | ---- | -34.12%-10.17M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -23.70%2M | ---- | 128.75%2.62M | ---- | -1,447.12%-9.13M | ---- | -169.41%-590K | ---- | -127.44%-219K |
| Accounts receivable (increase)decrease | ---- | 64.17%-1.42M | ---- | -133.76%-3.97M | ---- | 235.20%11.76M | ---- | -595.76%-8.7M | ---- | -153.26%-1.25M |
| Accounts payable increase (decrease) | ---- | -121.31%-1.15M | ---- | 4,562.81%5.4M | ---- | 99.17%-121K | ---- | -178.89%-14.66M | ---- | 647.51%18.58M |
| prepayments (increase)decrease | ---- | 21,500.00%1.5M | ---- | 99.58%-7K | ---- | -586.67%-1.65M | ---- | 93.51%-240K | ---- | -10,976.47%-3.7M |
| Special items for working capital changes | ---- | 107.03%165K | ---- | -225.23%-2.35M | ---- | 884.52%1.88M | ---- | -153.23%-239K | ---- | 283.27%449K |
| Cash from business operations | ---- | 134.97%1.43M | ---- | -151.94%-4.08M | ---- | 94.17%-1.62M | ---- | -853.89%-27.83M | ---- | 270.41%3.69M |
| Other taxs | ---- | 143.62%41K | ---- | 37.75%-94K | ---- | 13.71%-151K | ---- | -348.72%-175K | ---- | ---39K |
| Special items of business | 27.99%3.99M | ---- | 178.98%3.12M | ---- | -357.60%-3.95M | ---- | 147.52%1.53M | ---- | 5.76%-3.23M | ---- |
| Net cash from operations | 27.99%3.99M | 135.16%1.47M | 178.98%3.12M | -135.78%-4.18M | -357.60%-3.95M | 93.67%-1.77M | 147.52%1.53M | -866.73%-28M | 5.76%-3.23M | 268.61%3.65M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -94.74%1K | ---- | 850.00%19K | ---- | 0.00%2K | ---- | -81.82%2K | ---- | -73.17%11K |
| Decrease in deposits (increase) | ---- | ---- | ---- | --2.01M | ---- | ---- | ---- | 589.47%93K | ---- | 47.22%-19K |
| Purchase of fixed assets | ---- | -569.23%-348K | ---- | 84.43%-52K | ---- | 53.16%-334K | ---- | 94.98%-713K | ---- | -818.49%-14.21M |
| Other items in the investment business | -1,658.33%-211K | ---- | 76.00%-12K | ---- | 79.42%-50K | ---- | -151.37%-243K | ---- | 1,151.11%473K | ---- |
| Net cash from investment operations | -1,658.33%-211K | -117.57%-347K | 76.00%-12K | 694.88%1.98M | 79.42%-50K | 46.28%-332K | -151.37%-243K | 95.65%-618K | 1,151.11%473K | -842.77%-14.22M |
| Net cash before financing | 21.69%3.78M | 150.93%1.12M | 177.69%3.11M | -4.71%-2.2M | -410.00%-4M | 92.65%-2.1M | 146.86%1.29M | -170.88%-28.62M | 20.62%-2.75M | -187.56%-10.57M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 162.17%5.73M | ---- | --2.19M | ---- | ---- | ---- | 167.21%14.75M | ---- | --5.52M |
| Refund | ---- | ---280K | ---- | ---- | ---- | -66.24%-4.5M | ---- | -1,692.72%-2.71M | ---- | -3.42%-151K |
| Issuing shares | ---- | ---- | ---- | -37.70%7.87M | ---- | -52.14%12.64M | ---- | --26.4M | ---- | ---- |
| Interest paid - financing | ---- | -35.42%-780K | ---- | 55.79%-576K | ---- | 65.17%-1.3M | ---- | -29.31%-3.74M | ---- | -13.41%-2.89M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 88.12%-60K | ---- | 4.54%-505K | ---- | -71.75%-529K | ---- | -33.91%-308K |
| Other items of the financing business | -202.14%-2.54M | ---- | -116.60%-840K | ---- | 147.63%5.06M | ---- | -1.83%2.04M | ---- | 315.87%2.08M | ---- |
| Net cash from financing operations | -202.14%-2.54M | -76.62%871K | -116.60%-840K | 242.69%3.73M | 147.63%5.06M | -96.26%1.09M | -1.83%2.04M | 281.42%29.08M | 315.87%2.08M | 301.74%7.63M |
| Effect of rate | -17.66%-3.17M | 99.35%-4K | -567.49%-2.69M | -879.37%-617K | 75.23%-403K | -400.00%-63K | -1,141.98%-1.63M | -43.24%21K | -103.92%-131K | 147.44%37K |
| Net Cash | -45.17%1.24M | 30.95%1.99M | 113.87%2.27M | 249.66%1.52M | -68.20%1.06M | -319.18%-1.02M | 595.98%3.33M | 115.78%464K | 84.84%-672K | -65.54%-2.94M |
| Begining period cash | 51.49%5.85M | 30.59%3.86M | 30.59%3.86M | -26.75%2.96M | -26.75%2.96M | 13.65%4.04M | 13.65%4.04M | -44.97%3.55M | -44.97%3.55M | -22.31%6.46M |
| Cash at the end | 14.24%3.93M | 51.49%5.85M | -4.84%3.44M | 30.59%3.86M | -37.06%3.62M | -26.75%2.96M | 108.87%5.74M | 13.65%4.04M | -48.72%2.75M | -44.97%3.55M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.